Related LncRNAs
ID	lncRNA Name	Disease	Method	Sample	Expression pattern	Dysfunction type	Description	PMID	Source
EL0989	NPAP1	Angelman syndrome	N/A	N/A	N/A	expression	C15orf2 and a novel noncoding transcript from the Prader-Willi/Angelman syndrome region show monoallelic expression in fetal brain.	17337158	LncRNADisease
EL1224	SNHG14	Angelman syndrome	N/A	N/A	N/A	locus	Ube3a-as is a lncRNA transcribed antisense to the maternally expressed Ube3a gene, a candidate gene for AS, suggesting that Ube3a-as may be responsible for repressing paternal Ube3a expression.	20380817	LncRNADisease
EL1224	SNHG14	Angelman syndrome	N/A	N/A	N/A	regulation	LncRNAs are also associated with imprinting disorders, such as ubiquitin protein ligase E3A (UBE3A)-ATS in Angelman syndrome.	23562612	LncRNADisease
EL1224	SNHG14	Angelman syndrome	N/A	N/A	N/A	expression	Prader–Willi and Angelman syndromes, due to UBE3A expression, are affected due to the presence of a 20-kb NAT, which shares complementary sequences of UBE3A	23781896	LncRNADisease
EL1224	SNHG14	Angelman syndrome	N/A	N/A	N/A	regulation	Genomic context links lncRNAs to disease genes/loci and related pathways	23791884	LncRNADisease
EL1224	SNHG14	Angelman syndrome	N/A	N/A	N/A	mutation	Although in the majority of human tissues, both copies of the UBE3A gene are expressed, in neurons one copy is silenced by UBE3A-AS1 (ubiquitin-protein ligase E3A antisense RNA 1). In patients suffering from Angelman syndrome, the other (active) allele has either been deleted or inactivated.	24667321	LncRNADisease
EL1405	Ube3a-ATS	Angelman syndrome	N/A	N/A	N/A	N/A	ASO treatment achieved specific reduction of Ube3a-ATS and sustained unsilencing of paternal Ube3a in neurons in vitro and in vivo. Partial restoration of UBE3A protein in an Angelman syndrome mouse model ameliorated some cognitive deficits associated with the disease.	25470045	LncRNADisease